Highlights
NASDAQ: BIOC       Biocept Inc
Last Price Today's Change   Day's Range   Trading Volume
0.284   +0.009 (3.27%)  0.273 - 0.285  726,249

Overview

 
Avg Volume (4 weeks):3,134,283
4 Weeks Range:0.26 - 0.615
4 Weeks Price Volatility (%):
6.76%
52 Weeks Range:0.26 - 2.75
52 Weeks Price Volatility (%):
0.96%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), gastric cancer, colorectal cancer, prostate cancer and melanoma.

  Be the first to like this.
 


 

5109  2260  622  588 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SPY 274.71+4.31 
 CHK 3.200.00 
 GE 14.49-0.13 
 BAC 32.03+0.34 
 QQQ 168.17+3.37 
 MU 46.53+2.28 
 HPE 18.14+1.73 
 EEM 49.72+0.87 
 XLF 29.12+0.43 
 UVXY 14.82-2.66 
Partners & Brokers